Prosperity Consulting Group LLC Has $387,000 Stock Holdings in Danaher Corporation (NYSE:DHR)

Prosperity Consulting Group LLC cut its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 62.5% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 1,887 shares of the conglomerate's stock after selling 3,142 shares during the period. Prosperity Consulting Group LLC's holdings in Danaher were worth $387,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Fortis Capital Advisors LLC increased its holdings in shares of Danaher by 1.3% in the 4th quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate's stock valued at $914,000 after acquiring an additional 50 shares during the last quarter. Fayez Sarofim & Co grew its stake in shares of Danaher by 0.6% in the fourth quarter. Fayez Sarofim & Co now owns 8,287 shares of the conglomerate's stock worth $1,902,000 after purchasing an additional 50 shares in the last quarter. Coastal Bridge Advisors LLC raised its position in shares of Danaher by 4.8% during the 4th quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate's stock worth $252,000 after buying an additional 50 shares in the last quarter. Perennial Investment Advisors LLC increased its stake in shares of Danaher by 2.2% during the fourth quarter. Perennial Investment Advisors LLC now owns 2,343 shares of the conglomerate's stock valued at $538,000 after acquiring an additional 51 shares during the period. Finally, MGO One Seven LLC lifted its position in Danaher by 1.3% in the fourth quarter. MGO One Seven LLC now owns 4,285 shares of the conglomerate's stock worth $984,000 after purchasing an additional 53 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of several recent research reports. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Royal Bank Of Canada reissued an "outperform" rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, April 23rd. Leerink Partners lifted their price target on Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 23rd. Argus cut their price target on shares of Danaher from $260.00 to $240.00 in a report on Wednesday, April 23rd. Finally, Robert W. Baird raised their target price on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research report on Friday, July 18th. Three investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and a consensus target price of $247.61.

Danaher Trading Down 1.3%

Danaher stock traded down $2.61 during midday trading on Wednesday, hitting $204.24. 5,692,474 shares of the stock were exchanged, compared to its average volume of 4,032,979. The stock has a market capitalization of $146.25 billion, a PE ratio of 43.46, a P/E/G ratio of 2.87 and a beta of 0.77. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $281.70. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The company has a fifty day simple moving average of $196.69 and a two-hundred day simple moving average of $203.24.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's revenue for the quarter was up 3.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.72 EPS. Equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, July 25th. Investors of record on Friday, June 27th were issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.63%. Danaher's payout ratio is currently 27.23%.

Insiders Place Their Bets

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman directly owned 3,105,808 shares of the company's stock, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is currently owned by company insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.